The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Abstract
Skeletal homeostasis is determined by systemic hormones and local factors. Bone morphogenetic proteins (BMP) are unique because they induce the differentiation of mesenchymal cells toward cells of the osteoblastic lineage and also enhance the differentiated function of the osteoblast. However, the activity of BMPs needs to be tempered by intracellular and extracellular antagonists. BMPs bind to specific receptors and signal by phosphorylating the cytoplasmic proteins mothers against decapentaplegic (Smad) 1 and 5, which form heterodimers with Smad 4, and after nuclear translocation regulate transcription. BMP antagonists can be categorized as pseudoreceptors that compete with signaling receptors, inhibitory Smads that block signaling, intracellular binding proteins that bind Smad 1 and 5, and factors that induce ubiquitination and proteolysis of signaling Smads. In addition, a large number of extracellular proteins that bind BMPs and prevent their binding to signaling receptors have emerged. They are the components of the Spemann organizer, noggin, chordin, and follistatin, members of the Dan/Cerberus family, and twisted gastrulation. The antagonists tend to be specific for BMPs and are regulated by BMPs, indicating the existence and need of local feedback mechanisms to temper BMP cellular activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes
Helvering, L. M., Sharp, R. L., Ou, X., & Geiser, A. G. (2000) · Gene · doi:10.1016/s0378-1119(00)00364-4 · Cited by 98
The Mouse Bone Morphogenetic Protein-4 Gene
Feng, J. Q., Chen, D., Cooney, A. J., Tsai, M., Harris, M. A., Tsai, S. Y., Feng, M., Mundy, G. R., & Harris, S. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28364 · Cited by 95
Rickard, D. J., Hofbauer, L. C., Bonde, S. K., Gori, F., Spelsberg, T. C., & Riggs, B. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119880 · Cited by 93
Characterization of GDF-10 Expression Patterns and Null Mice
Zhao, R., Lawler, A. M., & Lee, S.-J. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9326 · Cited by 92
Yamanaka, R., Lekstrom-Himes, J. A., Barlow, C., Wynshaw-Boris, A. J., & Xanthopoulos, K. G. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.1.213 · Cited by 91
Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin.
Hashimoto, M., Shoda, A., Inoue, S., Yamada, R., Kondo, T., Sakurai, T., Ueno, N., & Muramatsu, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42930-4 · Cited by 89
DAN is a secreted glycoprotein related to Xenopus cerberus
Stanley, E. G., Biben, C., Kotecha, S., Fabri, L., Tajbakhsh, S., Wang, C.-C., Hatzistavrou, T., Roberts, B., Drinkwater, C. C., Lah, M. S., et al. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00139-7 · Cited by 89
XBF-2 is a transcriptional repressor that converts ectoderm into neural tissue
Mariani, F. V., & Harland, R. M. (1998) · Development · doi:10.1242/dev.125.24.5019 · Cited by 89
Marcelino, J. R., Sciortino, C. M., Romero, M. F., Ulatowski, L. M., Ballock, R. T., Economides, A. N., Eimon, P. M., Harland, R. M., & Warman, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201367598 · Cited by 88
Self-citationDionne, M., Skarnes, W. C., & Harland, R. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.636-643.2001 · Cited by 87
Leong, G. M., Subramaniam, N., Figueroa, J. D., Flanagan, J., Hayman, M. J., Eisman, J. A., & Kouzmenko, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010815200 · Cited by 85
Namiki, M., Akiyama, S., Katagiri, T., Suzuki, A., Ueno, N., Yamaji, N., Rosen, V., Wozney, J. M., & Suda, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22046 · Cited by 84
Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.
Enomoto, H., Ozaki, T., Takahashi, E., Nomura, N., Tabata, S., Takahashi, H., Ohnuma, N., Tanabe, M., Iwai, J., & Yoshida, H. (1994) · PubMed · Cited by 79
Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
Gitelman, S. E., Kirk, M., Ye, J., Filvaroff, E. H., Kahn, A., & Derynck, R. (1995) · PubMed · Cited by 77
Knutsen, R., Honda, Y., Strong, D. D., Sampath, T. K., Baylink, D. J., & Mohan, S. (1995) · Endocrinology · doi:10.1210/endo.136.3.7532581 · Cited by 69
The Bone Morphogenetic Proteins Antagonist Noggin Inhibits Membranous Ossification
Aspenberg, P., Jeppsson, C., & Economides, A. N. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.497 · Cited by 65
Self-citationChen, T. L., Shen, W., & Kraemer, F. B. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1145 · Cited by 63
Regulation of Collagenase-3 by Bone Morphogenetic Protein-2 in Bone Cell Cultures*
Varghese, S., & CANALIS, E. M. (1997) · Endocrinology · doi:10.1210/endo.138.3.4978 · Cited by 61
Self-citationThe insulin-like growth factor-binding protein superfamily
Rosenfeld, R. G., Hwa, V., Wilson, E., Plymate, S. R., & Oh, Y. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)90007-8 · Cited by 55
Minabe‐Saegusa, C., Saegusa, H., Tsukahara, M., & Noguchi, S. (1998) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.1998.t01-1-00010.x · Cited by 55
CANALIS, E. M., & Gabbitas, B. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091221 · Cited by 52
Self-citationGomes, W. A., & Kessler, J. A. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0344 · Cited by 51
Spemann organizer activity of Smad10
LeSueur, J. A., & Graff, J. M. (1999) · Development · doi:10.1242/dev.126.1.137 · Cited by 49
Follistatin and activin in bone: expression and localization during endochondral bone development
Funaba, M., Ogawa, K., Murata, T., Fujimura, H., Murata, E., Abe, M., Takahashi, M., & Torii, K. (1996) · Endocrinology · doi:10.1210/en.137.10.4250 · Cited by 48
Krishnan, V., Ma, Y. L., Moseley, J. M., Geiser, A. G., Friant, S., & Frolik, C. A. (2001) · Endocrinology · doi:10.1210/en.142.2.940 · Cited by 42
Regulation of the expression of follistatin in rat hepatocytes
Zhang, Y.-Q., Kanzaki, M., Shibata, H., & Kojima, I. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00085-7 · Cited by 36
Invited review of a workshop: anabolic hormones in bone: basic research and therapeutic potential
Margolis, R., CANALIS, E. M., & Partridge, N. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772542 · Cited by 35
Self-citationAnalysis of Type-I and Type-II RUNX2 Protein Expression in Osteoblasts
Sudhakar, S., Katz, M. S., & Elango, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5363 · Cited by 33
Cloning of the chick BMP1/Tolloid cDNA and expression in skeletal tissues
Reynolds, S. D., Zhang, D., Puzas, J. E., O’Keefe, R. J., Rosier, R. N., & Reynolds, P. R. (2000) · Gene · doi:10.1016/s0378-1119(00)00114-1 · Cited by 31
Takazawa, Y., Tsuji, K., Nifuji, A., Kurosawa, H., Ito, Y., & Noda, M. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650579 · Cited by 31
Cloning and characterization of the mouseXPACgene
van Oostrom, C. T. M., de Vries, A., Verbeek, S. J., van Kreijl, C. F., & STEEG, H. V. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.1.11 · Cited by 29
Yang, X., Matsuura, H., Yan, F., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01285-0 · Cited by 24
Delany, A. M., & CANALIS, E. M. (1997) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(97)80005-5 · Cited by 10
Self-citation
Cited by
Nature’s hierarchical materials
Fratzl, P., & Weinkamer, R. (2007) · Progress in Materials Science · doi:10.1016/j.pmatsci.2007.06.001 · Cited by 2,800
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure
Tseng, Y.-H., Kokkotou, E., Schulz, T. J., Huang, T. L., Winnay, J. N., Taniguchi, C. M., Tran, T. T., Suzuki, R., Espinoza, D. O., Yamamoto, Y., et al. (2008) · Nature · doi:10.1038/nature07221 · Cited by 1,099
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citation
Metadata
- Authors
- Canalis, E., Economides, A. N., & Gazzerro, E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 24
- Issue
- 2
- Pages
- 218-235
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2110149781
- Cited by
- 863
- References
- 233
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.